# Phase 2 Liver Cirrhosis trials recruiting: 25 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials in phase 2 for Liver Cirrhosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Liver Cirrhosis trials: 25 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/liver-cirrhosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 25
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07933328 | Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD) | Regeneron Pharmaceuticals | Phase 2 | Not yet recruiting | Alcohol-Associated Liver Disease, ALD | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933328) |
| September 28, 2026 | NCT07843420 | Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus | Mayo Clinic | Phase 2 | Not yet recruiting | Chronic Hepatic Pruritus, Cholestatic Liver Disease, Primary Biliary Cholangitis, Cholestasis, Primary Sclerosing... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843420) |
| September 25, 2026 | NCT07841977 | Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis | Gilead Sciences | Phase 2 | Recruiting | Primary Biliary Cholangitis | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841977) |
| July 2, 2026 | NCT07681089 | A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia | Sponsor not shown (see the record) | Phase 2 | Recruiting | Liver Cirrhosis | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07681089) |
| July 1, 2026 | NCT07678645 | The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching | RenJi Hospital | Phase 2 | Not yet recruiting | Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Atopic Dermatitis (AD) | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07678645) |
| June 8, 2026 | NCT07631637 | Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Regeneron Pharmaceuticals | Phase 2 | Recruiting | Metabolic Dysfunction-Associated Steatohepatitis, MASH | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07631637) |
| May 28, 2026 | NCT07610837 | Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis | AstraZeneca | Phase 2 | Recruiting | Liver Fibrosis, Hepatic Cirrhosis | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610837) |
| January 20, 2026 | NCT07350070 | TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension | Tongji Hospital | Phase 2 | Not yet recruiting | HCC, Liver Cirrhosis, Portal Hypertension | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07350070) |
| January 8, 2026 | NCT07325526 | A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated... | Boehringer Ingelheim | Phase 2 | Recruiting | Liver Cirrhosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325526) |
| August 28, 2025 | NCT07145268 | Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy | Tanta University | Phase 2 | Not yet recruiting | Liver Fibroses, HBV (Hepatitis B Virus) | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07145268) |
| March 21, 2025 | NCT06890039 | A-TANGO Phase 2 Study | Yaqrit Ltd | Phase 2 | Recruiting | Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06890039) |
| December 13, 2024 | NCT06733519 | TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis | Tharimmune Inc | Phase 2 | Not yet recruiting | Pruritus, Primary Biliary Cholangitis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06733519) |
| September 19, 2024 | NCT06599918 | Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Phase 2 | Recruiting | Fatty Liver, Obesity, Hepatic Fibrosis, NAFLD, Nicotinamide, Overweight and Obese Adults | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06599918) |
| September 19, 2024 | NCT06588699 | Digoxin In NASH (CODIN) | Yale University | Phase 2 | Recruiting | NASH, NAFLD, MASH - Metabolic Dysfunction-Associated Steatohepatitis, Mash, MASH With Fibrosis, MASLD, Fatty Liver... | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06588699) |
| July 29, 2024 | NCT06526104 | Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis | The University of Texas Health Science Center at San Antonio | Phase 2 | Recruiting | Hepatocellular Carcinoma, Cirrhosis, Liver | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06526104) |
| August 29, 2023 | NCT06015022 | EGCG for Hepatocellular Carcinoma Chemoprevention | University of Texas Southwestern Medical Center | Phase 2 | Recruiting | Cirrhosis, Liver | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06015022) |
| June 8, 2023 | NCT05895136 | A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT... | European Foundation for Study of Chronic Liver Failure | Phase 2 | Recruiting | Liver Cirrhosis, Decompensated Cirrhosis of Liver, Acute on Chronic Liver Failure (ACLF) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05895136) |
| May 22, 2023 | NCT05869591 | DOAC in Patients with Child a or B Liver Cirrhosis | Centre Hospitalier Universitaire Vaudois | Phase 2 | Recruiting | Liver Cirrhosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05869591) |
| May 22, 2023 | NCT05867602 | High Dose Albumin in Refractory Ascites | Baylor College of Medicine | Phase 2 | Recruiting | Ascites | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05867602) |
| April 27, 2023 | NCT05832229 | Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | Recruiting | Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious... | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05832229) |
| September 2, 2022 | NCT05526144 | Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans | VA Office of Research and Development | Phase 2 | Recruiting | Nonalcoholic Steatohepatitis, Liver Fibrosis | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05526144) |
| August 31, 2021 | NCT05028829 | Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk | Sponsor not shown (see the record) | Phase 2 | Recruiting | Liver Fibroses, Cirrhosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05028829) |
| May 5, 2021 | NCT04873102 | Danazol for Treatment of Cytopenias in Patients With Cirrhosis | University of Southern California | Phase 2 | Recruiting | Cirrhosis, Liver, Cytopenia | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04873102) |
| January 31, 2020 | NCT04250259 | SAMe Trial for Patients With Alcoholic Cirrhosis | Indiana University | Phase 2 | Recruiting | Alcoholic Cirrhosis | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04250259) |
| November 21, 2019 | NCT04172779 | Erlotinib for Hepatocellular Carcinoma Chemoprevention | University of Texas Southwestern Medical Center | Phase 2 | Not yet recruiting | Cirrhosis, Liver, Advanced Liver Fibrosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04172779) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Texas Southwestern Medical Center | 2 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 2 |
| Tanta University | 1 |
| [Gilead Sciences](https://specstream.ai/data/clinical-trials/company/gilead-sciences) | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Tharimmune Inc | 1 |
| University of Southern California | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Yale University | 1 |
| Yaqrit Ltd | 1 |
| Baylor College of Medicine | 1 |
| Indiana University | 1 |
| European Foundation for Study of Chronic Liver Failure | 1 |
| Mayo Clinic | 1 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 1 |
| Tongji Hospital | 1 |
| RenJi Hospital | 1 |
| VA Office of Research and Development | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 15 |
| United Kingdom | 3 |
| Puerto Rico | 2 |
| Spain | 2 |
| China | 2 |
| Switzerland | 1 |
| Japan | 1 |
| France | 1 |
| Germany | 1 |
| Italy | 1 |
| Canada | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Jewelry and watches manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-and-watches-manufacturers/united-states)
- [Civil engineering firms in the United States](https://specstream.ai/data/businesses/civil-engineering-firms/united-states)
- [Tapas bars in the United States](https://specstream.ai/data/businesses/tapas-bars/united-states)
- [Legal services firms in the United States](https://specstream.ai/data/businesses/legal-services-firms/united-states)
- [Computer wholesalers in the United States](https://specstream.ai/data/businesses/computer-wholesalers/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
